Features the director of FDA’s Center for Drug Evaluation and Research
Information about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development
Emerging safety information about drugs in conjunction with the release of Drug Safety Communications
Learn how CDER is advancing regulatory science to protect public health.
Early Engagement with FDA to Discuss Novel Surrogate Endpoints
November 27, 2018 Issue
PDF | Audio Podcast | Audio Transcript